Genesem Inc. (KOSDAQ: 217190)
South Korea
· Delayed Price · Currency is KRW
8,310.00
-800.00 (-8.78%)
Nov 15, 2024, 9:00 AM KST
Genesem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 72,495 | 56,454 | 59,603 | 59,727 | 41,942 |
Revenue Growth (YoY) | 30.72% | -5.28% | -0.21% | 42.41% | - |
Cost of Revenue | 43,679 | 36,627 | 35,601 | 39,109 | 30,204 |
Gross Profit | 28,816 | 19,827 | 24,002 | 20,619 | 11,738 |
Selling, General & Admin | 14,323 | 10,573 | 10,160 | 10,280 | 8,183 |
Research & Development | 4,931 | 4,385 | 4,161 | 3,583 | 2,975 |
Other Operating Expenses | 272.91 | 272.35 | 259.36 | 287.43 | 292.4 |
Operating Expenses | 20,608 | 16,265 | 15,484 | 14,985 | 12,782 |
Operating Income | 8,208 | 3,562 | 8,519 | 5,633 | -1,044 |
Interest Expense | -880.34 | -876.24 | -665.08 | -540.98 | -490.43 |
Interest & Investment Income | 346.07 | 320.22 | 157.35 | 18.89 | 17.17 |
Currency Exchange Gain (Loss) | 587.08 | 85.02 | 473.2 | 349.11 | -114.73 |
Other Non Operating Income (Expenses) | -87.02 | -7.44 | -103.38 | -139.39 | 524.93 |
EBT Excluding Unusual Items | 8,174 | 3,083 | 8,381 | 5,321 | -1,108 |
Gain (Loss) on Sale of Investments | 24.07 | 30.38 | 17.23 | 11.55 | 6.38 |
Gain (Loss) on Sale of Assets | -17.85 | - | - | 0.77 | 37.43 |
Asset Writedown | - | - | -15 | - | -64.39 |
Pretax Income | 8,180 | 3,114 | 8,383 | 5,333 | -1,128 |
Income Tax Expense | 318.41 | -482.29 | -3,807 | 90.66 | -69.6 |
Earnings From Continuing Operations | 7,861 | 3,596 | 12,190 | 5,242 | -1,059 |
Minority Interest in Earnings | 113.7 | 129.32 | 43.22 | 0.13 | - |
Net Income | 7,975 | 3,725 | 12,233 | 5,243 | -1,059 |
Net Income to Common | 7,975 | 3,725 | 12,233 | 5,243 | -1,059 |
Net Income Growth | -6.08% | -69.55% | 133.34% | - | - |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 |
EPS (Basic) | 909.45 | 424.82 | 1395.01 | 597.84 | -120.71 |
EPS (Diluted) | 909.45 | 424.82 | 1395.01 | 597.84 | -120.71 |
EPS Growth | -6.08% | -69.55% | 133.34% | - | - |
Free Cash Flow | 9,420 | 2,759 | 8,250 | 3,577 | -4,569 |
Free Cash Flow Per Share | 1074.20 | 314.65 | 940.75 | 407.85 | -521.00 |
Gross Margin | 39.75% | 35.12% | 40.27% | 34.52% | 27.99% |
Operating Margin | 11.32% | 6.31% | 14.29% | 9.43% | -2.49% |
Profit Margin | 11.00% | 6.60% | 20.52% | 8.78% | -2.52% |
Free Cash Flow Margin | 12.99% | 4.89% | 13.84% | 5.99% | -10.89% |
EBITDA | 9,460 | 4,779 | 9,715 | 6,828 | 48.31 |
EBITDA Margin | 13.05% | 8.46% | 16.30% | 11.43% | 0.12% |
D&A For EBITDA | 1,252 | 1,217 | 1,196 | 1,195 | 1,093 |
EBIT | 8,208 | 3,562 | 8,519 | 5,633 | -1,044 |
EBIT Margin | 11.32% | 6.31% | 14.29% | 9.43% | -2.49% |
Effective Tax Rate | 3.89% | - | - | 1.70% | - |
Advertising Expenses | - | 68.25 | 64.28 | 14.84 | 6 |
Source: S&P Capital IQ. Standard template. Financial Sources.